Pages that link to "Q34145245"
Jump to navigation
Jump to search
The following pages link to Antiangiogenic therapy for glioblastoma (Q34145245):
Displaying 28 items.
- Overview of Methods for Overcoming Hindrance to Drug Delivery to Tumors, with Special Attention to Tumor Interstitial Fluid (Q26799981) (← links)
- Circulating glioma biomarkers (Q26830329) (← links)
- Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods (Q26853516) (← links)
- Oncolytic herpes simplex virus-based strategies: toward a breakthrough in glioblastoma therapy (Q26998111) (← links)
- Migration capacity of human umbilical cord mesenchymal stem cells towards glioma in vivo (Q34095283) (← links)
- Current status of gene therapy for brain tumors. (Q34318157) (← links)
- Glioblastoma multiforme - an overview (Q34589068) (← links)
- Downregulation of programmed cell death 10 is associated with tumor cell proliferation, hyperangiogenesis and peritumoral edema in human glioblastoma (Q35816668) (← links)
- Single agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastoma (Q36575238) (← links)
- Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages. (Q36831553) (← links)
- Early monitoring antiangiogenesis treatment response of Sunitinib in U87MG Tumor Xenograft by (18)F-FLT MicroPET/CT imaging. (Q37725493) (← links)
- The VEGF pathway in lung cancer (Q38148460) (← links)
- Current status of antiangiogenic therapies for glioblastomas (Q38169761) (← links)
- Current Studies of Immunotherapy on Glioblastoma (Q38262914) (← links)
- Diffusion MRI Phenotypes Predict Overall Survival Benefit from Anti-VEGF Monotherapy in Recurrent Glioblastoma: Converging Evidence from Phase II Trials. (Q38706148) (← links)
- Resident microglia rather than peripheral macrophages promote vascularization in brain tumors and are source of alternative pro-angiogenic factors. (Q40157809) (← links)
- Induction of Mitochondrial Dysfunction and Oxidative Damage by Antibiotic Drug Doxycycline Enhances the Responsiveness of Glioblastoma to Chemotherapy. (Q41616841) (← links)
- Circulating progenitor cells: a comparison of patients with glioblastoma or meningioma (Q44548631) (← links)
- Vascular endothelial growth factor and KIT expression in relation with microvascular density and tumor grade in supratentorial astrocytic tumors. (Q45156573) (← links)
- New applications of nanotechnology for neuroimaging (Q48105603) (← links)
- Quantification of antiangiogenic treatment effects on tissue heterogeneity in glioma tumour xenograft model using a combination of DCE-MRI and 3D-ultramicroscopy (Q48235199) (← links)
- Therapeutic effects of LS-13 on glioma in vivo and in vitro. (Q48577210) (← links)
- Assessment of tumor oxygenation and its impact on treatment response in bevacizumab-treated recurrent glioblastoma (Q48918188) (← links)
- PI3K/AKT/Afadin signaling pathway contributes to pathological vascularization in glioblastomas (Q49725498) (← links)
- The vascular delta-like ligand-4 (DLL4)-Notch4 signaling correlates with angiogenesis in primary glioblastoma: an immunohistochemical study. (Q52147874) (← links)
- A three-dimensional (3D) organotypic microfluidic model for glioma stem cells - Vascular interactions (Q57174079) (← links)
- Treatment response of bevacizumab combination chemotherapy in recurrent glioblastoma: A long-term retrospective study in Taiwan (Q89809933) (← links)
- The Anti-Angiogenic Effect of Atorvastatin in Glioblastoma Spheroids Tumor Cultured in Fibrin Gel: in 3D in Vitro Model (Q91753256) (← links)